Morgan Stanley
GNRS

Morgan Stanley’s Greenrose Acquisition Corp. Common Stock GNRS Stock Holding History

Morgan Stanley’s Portfolio GNRS Stock Details GNRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-36,650
Closed -$365K – 7921
2021
Q1 		$365K Buy
36,650
+36,558
+39,737% +$377K ﹤0.01% 5325
2020
Q4 		$1K Buy
+92
New +$909 ﹤0.01% 7011

Other funds holding GNRS

KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Morgan Stanley's GNRS Position: Q2 2021 in Review

Morgan Stanley sold out of Greenrose Acquisition Corp. Common Stock (GNRS) in Q2 2021, closing a stake of 36,650 shares — an estimated $365K sold.

Morgan Stanley first reported a position in GNRS in Q4 2020 and held it in 2 quarters. The position peaked at $365K in Q1 2021. 14 funds tracked by Wall St. Rank hold GNRS as of Q2 2021.

  • Morgan Stanley reported no remaining Greenrose Acquisition Corp. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Morgan Stanley sold 36,650 Greenrose Acquisition Corp. Common Stock shares in Q2 2021, an estimated $365K.
  • Morgan Stanley first reported a position in Greenrose Acquisition Corp. Common Stock in Q4 2020 and held it in 2 quarters.
  • Morgan Stanley's Greenrose Acquisition Corp. Common Stock position peaked at $365K in Q1 2021.
  • 14 funds tracked by Wall St. Rank held Greenrose Acquisition Corp. Common Stock as of Q2 2021.

Based on Morgan Stanley's 13F filing for Q2 2021, filed 16 Aug 2021.